Research Topic

Epigenetic Mechanisms and Post-translational Modifications as Novel Therapeutic Targets in Cancer

About this Research Topic

The complex physiology of eukaryotic cells is regulated through numerous mechanisms, such as epigenetics and posttranslational modifications to name a few. The wide-ranging diversity of these mechanisms constitutes a way of dynamically regulating the functionality, activity, and subcellular localization of proteins, as well as modulating the differential expression of relevant genes that is dependent upon external and internal stimuli tallowing an organism to adapt accordingly. Up until now, there has been a growing awareness that dysregulation of epigenetics and posttranslational modifications does play a significant role in many types of diseases, especially in cancer, and this has fueled more research to focus on drug discovery. Nevertheless, only a select few number of studies have actually moved into human clinical trials.

While epigenetics and posttranslational modifications are hot topics in cancer research, only several small compounds have been approved to be tested by clinical trials. Many questions and underlying mechanisms still remain unanswered and unclear, especially when it comes to the cross talk among these epigenetics and posttranslational modifications, the identification of novel compound backbones for these targeting drugs, the biological function of epigenetics and posttranslational modifications in metabolism, cancer targeting immunotherapies, drug resistance, phase change, ferroptosis, and pyroptosis. Hence, further studies that will advance the present understanding of epigenetics and posttranslational modifications and therapeutics targeting them in cancer are very much warranted.

As a fastly growing area of research, the interplay between epigenetics and posttranslational modifications as it relates to cancer drug discovery proves to be quite a promising focus point to discover life-saving therapies. For this Research Topic, we invite authors to submit Original Research and Review articles that provide novel insights into the field of epigenetics and posttranslational modifications and their potential as therapeutic targets in cancer, including but not limited to:

• Epigenetic and posttranslational modification related molecular mechanisms.
• Drug target identification and drug discovery.
• Assay development, molecular modeling and target structure analysis that also include an experimental component ( in vitro or in vivo ).


Keywords: Drug target, Posttranslational modification, Cancer, Therapeutics, Epigenetics


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

The complex physiology of eukaryotic cells is regulated through numerous mechanisms, such as epigenetics and posttranslational modifications to name a few. The wide-ranging diversity of these mechanisms constitutes a way of dynamically regulating the functionality, activity, and subcellular localization of proteins, as well as modulating the differential expression of relevant genes that is dependent upon external and internal stimuli tallowing an organism to adapt accordingly. Up until now, there has been a growing awareness that dysregulation of epigenetics and posttranslational modifications does play a significant role in many types of diseases, especially in cancer, and this has fueled more research to focus on drug discovery. Nevertheless, only a select few number of studies have actually moved into human clinical trials.

While epigenetics and posttranslational modifications are hot topics in cancer research, only several small compounds have been approved to be tested by clinical trials. Many questions and underlying mechanisms still remain unanswered and unclear, especially when it comes to the cross talk among these epigenetics and posttranslational modifications, the identification of novel compound backbones for these targeting drugs, the biological function of epigenetics and posttranslational modifications in metabolism, cancer targeting immunotherapies, drug resistance, phase change, ferroptosis, and pyroptosis. Hence, further studies that will advance the present understanding of epigenetics and posttranslational modifications and therapeutics targeting them in cancer are very much warranted.

As a fastly growing area of research, the interplay between epigenetics and posttranslational modifications as it relates to cancer drug discovery proves to be quite a promising focus point to discover life-saving therapies. For this Research Topic, we invite authors to submit Original Research and Review articles that provide novel insights into the field of epigenetics and posttranslational modifications and their potential as therapeutic targets in cancer, including but not limited to:

• Epigenetic and posttranslational modification related molecular mechanisms.
• Drug target identification and drug discovery.
• Assay development, molecular modeling and target structure analysis that also include an experimental component ( in vitro or in vivo ).


Keywords: Drug target, Posttranslational modification, Cancer, Therapeutics, Epigenetics


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

31 May 2021 Abstract
30 September 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

31 May 2021 Abstract
30 September 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..